4.7 Article

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19

Dana Crisan et al.

Summary: This study evaluates the role of abnormal liver tests and non-invasive fibrosis estimators in the prognosis of hospitalized COVID-19 patients. It found that severe fibrosis estimators scores and elevated aspartate aminotransferase are independently associated with mortality, suggesting that high FIB-4 scores may serve as a predictor for survival in COVID-19 patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease

Mohamed A. Elfeki et al.

Summary: This study found that elevated pre-infection FIB-4 index in patients at risk of NAFLD with COVID-19 infection was associated with worsened clinical outcomes, but age was the strongest predictor.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Gastroenterology & Hepatology

Evaluation of Non-invasive Fibrosis Markers in Predicting Esophageal Variceal Bleeding

Sami Cifci et al.

Summary: This study found that patients with cirrhosis who experienced EVB had decreased platelet levels, while their APRI, AARPRI, FIB-4, and S-index levels were higher. FIB-4, AARPRI, PLT were identified as significant predictors for EVB in cirrhosis patients.

CLINICAL ENDOSCOPY (2021)

Article Clinical Neurology

Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage

Huan Wang et al.

Summary: In Chinese patients with primary ICH, liver fibrosis indices are independently associated with a higher risk of substantial HE, suggesting that subclinical liver fibrosis should be routinely assessed in such patients to identify those at high risk of substantial HE.

BMC NEUROLOGY (2021)

Article Gastroenterology & Hepatology

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19

Alejandro Campos-Murguia et al.

Summary: This study evaluated the presence of MAFLD and fibrosis in patients with COVID-19 and its association with prognosis. The presence of liver fibrosis was associated with higher severity scores, inflammatory markers, mechanical ventilation requirement, AKI incidence, and mortality.

DIGESTIVE AND LIVER DISEASE (2021)

Review Oncology

COVID-19: immunopathology, pathophysiological mechanisms, and treatment options

Larissa E. van Eijk et al.

Summary: COVID-19, caused by SARS-CoV-2, is a complex viral disease with varying symptoms, understanding its immunopathology and developing effective treatment strategies are crucial. Pathological observations provide valuable insights, current management strategies include supportive care and drug therapy.

JOURNAL OF PATHOLOGY (2021)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Review Nutrition & Dietetics

Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis

Lucilla Crudele et al.

Summary: The prevalence of overweight and obesity has increased dramatically worldwide in recent years, leading to a higher risk of chronic diseases such as cancer. Strategies focused on limiting fat accumulation and lifestyle interventions are crucial to prevent cancer and reduce excess body weight.

NUTRIENTS (2021)

Article Multidisciplinary Sciences

AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects

Carlo De Matteis et al.

Summary: Visceral obesity is associated with non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk. The non-invasive serum marker APRI has been validated as a predictor of cardiovascular risk, especially showing a significant increase in younger female patients.

SCIENTIFIC REPORTS (2021)

Article Gastroenterology & Hepatology

Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19

Yijia Li et al.

Summary: The study found that FIB-4 score is associated with mortality in COVID-19 hospitalized patients, with each unit increase in FIB-4 score linked to higher risk of death. FIB-4 score peaked and then normalized in the survivor group but failed to do so in the deceased group. Furthermore, FIB-4 was positively correlated with SARS-CoV-2 viral load and monocyte-associated cytokines, particularly interleukin-6 and interferon gamma-induced protein 10.

HEPATOLOGY COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2

Kun Sun et al.

Summary: The study shows that ACE2 is highly conserved in various mammals, with expression in certain human tissues consistent with clinical symptoms of COVID-19 patients. Cats and dogs exhibit exceptionally high ACE2 expression in external body parts, suggesting they may be vulnerable to viral infections.

HELIYON (2021)

Editorial Material Gastroenterology & Hepatology

Evidence for Gastrointestinal Infection of SARS-CoV-2

Fei Xiao et al.

GASTROENTEROLOGY (2020)

Article Endocrinology & Metabolism

Complications, morbidity and mortality of nonalcoholic fatty liver disease

Alessandro Mantovani et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Endocrinology & Metabolism

Obesity and its Implications for COVID-19 Mortality

William Dietz et al.

OBESITY (2020)

Review Gastroenterology & Hepatology

Abnormal Liver Function Tests in Patients WithCOVID-19: Relevance and Potential Pathogenesis

Anna Bertolini et al.

HEPATOLOGY (2020)

Review Public, Environmental & Occupational Health

COVID-19 and comorbidities: Deleterious impact on infected patients

Hasan Ejaz et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Letter Gastroenterology & Hepatology

COVID-19 and the liver: little cause for concern

Mansoor N. Bangash et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Virology

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19

Kishan P. Patel et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Editorial Material Medicine, General & Internal

Covid-19 and Disparities in Nutrition and Obesity

Matthew J. Belanger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Gastroenterology & Hepatology

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Stuart McPherson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Multidisciplinary Sciences

New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis

Hung-Wei Wang et al.

SCIENTIFIC REPORTS (2017)

Review Medicine, General & Internal

Obesity and respiratory diseases

Christopher Zammit et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2010)

Review Medicine, General & Internal

Pulmonary complications of obesity

SM Koenig

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2001)

Article Medicine, General & Internal

Prevalence of and risk factors for hepatic steatosis in northern Italy

S Bellentani et al.

ANNALS OF INTERNAL MEDICINE (2000)